Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Ying Xue, Xiaoye Li, Zi Wang & Qianzhou Lv. (2022) Cilostazol regulates the expressions of endothelin‑1 and endothelial nitric oxide synthase via activation of the p38 MAPK signaling pathway in HUVECs. Biomedical Reports 17:3.
Crossref
Crossref
Sadia Hassan, Murtaza Najabat Ali & Bakhtawar Ghafoor. (2022) Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach. Journal of Cardiothoracic Surgery 17:1.
Crossref
Crossref
Alberto Arencibia, Fernando Lanas & Luis A. Salazar. (2022) Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis. International Journal of Molecular Sciences 23:6, pages 3074.
Crossref
Crossref
Hiroshi Iwata, Eric A. Osborn, Giovanni J. Ughi, Kentaro Murakami, Claudia Goettsch, Joshua D. Hutcheson, Adam Mauskapf, Peter C. Mattson, Peter Libby, Sasha A. Singh, Joan Matamalas, Elena Aikawa, Guillermo J. Tearney, Masanori Aikawa & Farouc A. Jaffer. (2021) Highly Selective PPARα (Peroxisome Proliferator‐Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular‐Microstructural Imaging. Journal of the American Heart Association 10:20.
Crossref
Crossref
Lukasz Piotr Zielinski, Mohammed M. Chowdhury & Patrick A. Coughlin. (2021) Patient and Institutional Costs of Failure of Angioplasty of the Superficial Femoral Artery. Annals of Vascular Surgery 72, pages 218-226.
Crossref
Crossref
Tommaso Gori. (2021) Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure. Life 11:1, pages 63.
Crossref
Crossref
Woohyeun Kim, Jin-Seok Kim, Seung-Woon Rha, Byoung Geol Choi, Won Young Jang, Dong Oh Kang, Yoonjee Park, Jah Yeon Choi, Seung-Young Roh, Jin Oh Na, Cheol Ung Choi, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Se Yeon Choi, Jae Kyeong Byun, Jinah Cha, Dong Joo Oh & Myung Ho Jeong. (2020) Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart and Vessels 35:9, pages 1181-1192.
Crossref
Crossref
Mohsen Maleknia, Narges Ansari, Habib Haybar, Mahmood Maniati & Najmaldin Saki. (2020) Inflammatory Growth Factors and In-Stent Restenosis: Effect of Cytokines and Growth Factors. SN Comprehensive Clinical Medicine 2:4, pages 397-407.
Crossref
Crossref
Ji-Bing Du, Wei Zhang, Na Li, Hua Jiang, Yin Liu, Jing Gao, Shu-Tao Chen, Hong-Liang Cong & Yi-Liang Wei. (2019) Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population. Journal of International Medical Research 48:1, pages 030006051982714.
Crossref
Crossref
Ying Xue, Zhi-wei Feng, Xiao-ye Li, Zi-heng Hu, Qing Xu, Zi Wang, Jia-hui Cheng, Hong-tao Shi, Qi-bing Wang, Hong-yi Wu, Xiang-Qun Xie & Qian-zhou Lv. (2017) The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis. Acta Pharmacologica Sinica 39:2, pages 205-212.
Crossref
Crossref
Qing Zhu, Xian-Qiang Ni, Wei-Wei Lu, Jin-Sheng Zhang, Jin-Ling Ren, Di Wu, Yao Chen, Lin-Shuang Zhang, Yan-Rong Yu, Chao-Shu Tang & Yong-Fen Qi. (2017) Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway. Atherosclerosis 266, pages 212-222.
Crossref
Crossref
Gianmarco de Donato, Francesco Setacci, Mariagnese Mele, Giovanni Giannace, Giuseppe Galzerano & Carlo Setacci. (2017) Restenosis after Coronary and Peripheral Intervention: Efficacy and Clinical Impact of Cilostazol. Annals of Vascular Surgery 41, pages 300-307.
Crossref
Crossref
Ying Shen, Chang Li, Rui Yan Zhang, Qi Zhang, Wei Feng Shen, Feng Hua Ding & Lin Lu. (2017) Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells. International Journal of Cardiology 228, pages 129-136.
Crossref
Crossref
Yukinori Harada, Roisin Colleran, Sebastian Kufner, Daniele Giacoppo, Tobias Rheude, Jonathan Michel, Salvatore Cassese, Tareq Ibrahim, Karl-Ludwig Laugwitz, Adnan Kastrati & Robert A. Byrne. (2016) Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. Cardiovascular Diabetology 15:1.
Crossref
Crossref
Janine Hussner, Juliane Sünwoldt, Isabell Seibert, Daniel G. Gliesche & Henriette E. Meyer zu Schwabedissen. (2016) Pimecrolimus increases the expression of interferon-inducible genes that modulate human coronary artery cells proliferation. European Journal of Pharmacology 784, pages 137-146.
Crossref
Crossref
Anwer Habib & Aloke Virmani Finn. (2016) Antiproliferative Drugs for Restenosis Prevention. Interventional Cardiology Clinics 5:3, pages 321-329.
Crossref
Crossref
Shi-jie Zhao, Zhao-shuang Zhong, Guo-xian Qi, Li-ye Shi, Ling Chen & Wen Tian. (2016) Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis. PLOS ONE 11:5, pages e0155273.
Crossref
Crossref
Kevin P. Bliden, Udaya S. Tantry, Martin G. Gesheff, Christopher J. Franzese, Shachi Pandya, Peter P. Toth, Denny P. Mathew, Rahul Chaudhary & Paul A. Gurbel. (2016) Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography. Journal of Interventional Cardiology 29:2, pages 168-178.
Crossref
Crossref
Sebastian Kufner, Jonas Sorges, Julinda Mehilli, Salvatore Cassese, Janika Repp, Jens Wiebe, Raphaela Lohaus, Annalena Lahmann, Tobias Rheude, Tareq Ibrahim, Steffen Massberg, Karl L. Laugwitz, Adnan Kastrati & Robert A. Byrne. (2016) Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents. JACC: Cardiovascular Interventions 9:8, pages 784-792.
Crossref
Crossref
Robert A. Byrne, Michael Joner & Adnan Kastrati. (2015) Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. European Heart Journal 36:47, pages 3320-3331.
Crossref
Crossref
Yandun Zou, Chunling Hu, Wenhui Ye, Limei Fan, Likun Xu & Aidong Zhang. (2015) Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials. Thrombosis Research 136:5, pages 870-877.
Crossref
Crossref
Zhengbin Zhu, Hui Han, Jinzhou Zhu, Jing Zhang, Run Du, Jingwei Ni, Chen Ying, Xuanqi An & Ruiyan Zhang. (2015) Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis. Bio-Medical Materials and Engineering 26:1-2, pages 79-88.
Crossref
Crossref